BMRN

NASDAQ · Biotechnology

Biomarin Pharmaceutical Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$54.06

-0.06 (-0.11%)

As of May 9, 1:09 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 25 81%

Hold 6 19%

Sell 0 0%

Price Target

Analyst Price Target +133.9% upside

Low Target $89.21

Average Target $126.44

High Target $194.19

Current Price $54.06

Current
$54.06

Target
$126.44

$89.21 $126.44 avg $194.19

Scenario Analysis

Bear Case

$89.21

65.0%

Low target

Base Case

$126.44

+133.9%

Avg target

Bull Case

$194.19

+259.2%

High target

Risk/Reward

4.0x

Highly favorable

Price in Context

52-Week High

$66.28

-18.4% from high

52-Week Low

$50.76

+6.5% from low

50-Day SMA

$57.48

-5.9% vs SMA

200-Day SMA

$56.51

-4.3% vs SMA

RSI (14)

80.7

Overbought

Target vs 52W High

$126.44

+90.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	72%	$257.58	+27.8%
AMGN Amgen Inc	Hold	43	49%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	26	96%	$143.40	+41.5%